Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.

Serum Bactericidal Activity (SBA) assay is the method of choice to evaluate the complement-mediated functional activity of both infection- and vaccine-induced antibodies. To perform a typical SBA assay, serial dilutions of sera are incubated with target bacterial strains and complement. The conventi...

Full description

Bibliographic Details
Main Authors: Francesca Necchi, Allan Saul, Simona Rondini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5305226?pdf=render
id doaj-4d2c6b4668ce4cb887ded02a3cc9d6dd
record_format Article
spelling doaj-4d2c6b4668ce4cb887ded02a3cc9d6dd2020-11-24T21:35:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017216310.1371/journal.pone.0172163Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.Francesca NecchiAllan SaulSimona RondiniSerum Bactericidal Activity (SBA) assay is the method of choice to evaluate the complement-mediated functional activity of both infection- and vaccine-induced antibodies. To perform a typical SBA assay, serial dilutions of sera are incubated with target bacterial strains and complement. The conventional SBA assay is based on plating on agar the SBA reaction mix and counting the surviving bacterial colony forming units (CFU) at each serum dilution. Even with automated colony counting, it is labor-intensive, time-consuming and not amenable for large-scale studies. Here, we have developed a luminescence-based SBA (L-SBA) method able to detect surviving bacteria by measuring their ATP. At the end of the SBA reaction, a single commercially available reagent is added to each well of the SBA plate, and the resulting luminescence signal is measured in a microplate reader. The signal obtained is proportional to the ATP present, which is directly proportional to the number of viable bacteria. Bactericidal activity is subsequently calculated. We demonstrated the applicability of L-SBA with multiple bacterial serovars, from 5 species: Citrobacter freundii, Salmonella enterica serovars Typhimurium and Enteritidis, Shigella flexneri serovars 2a and 3a, Shigella sonnei and Neisseria meningitidis. Serum bactericidal titers obtained by the luminescence readout method strongly correlate with the data obtained by the conventional agar plate-based assay, and the new assay is highly reproducible. L-SBA considerably shortens assay time, facilitates data acquisition and analysis and reduces the operator dependency, avoiding the plating and counting of CFUs. Our results demonstrate that L-SBA is a useful high-throughput bactericidal assay.http://europepmc.org/articles/PMC5305226?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Francesca Necchi
Allan Saul
Simona Rondini
spellingShingle Francesca Necchi
Allan Saul
Simona Rondini
Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.
PLoS ONE
author_facet Francesca Necchi
Allan Saul
Simona Rondini
author_sort Francesca Necchi
title Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.
title_short Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.
title_full Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.
title_fullStr Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.
title_full_unstemmed Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.
title_sort development of a high-throughput method to evaluate serum bactericidal activity using bacterial atp measurement as survival readout.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Serum Bactericidal Activity (SBA) assay is the method of choice to evaluate the complement-mediated functional activity of both infection- and vaccine-induced antibodies. To perform a typical SBA assay, serial dilutions of sera are incubated with target bacterial strains and complement. The conventional SBA assay is based on plating on agar the SBA reaction mix and counting the surviving bacterial colony forming units (CFU) at each serum dilution. Even with automated colony counting, it is labor-intensive, time-consuming and not amenable for large-scale studies. Here, we have developed a luminescence-based SBA (L-SBA) method able to detect surviving bacteria by measuring their ATP. At the end of the SBA reaction, a single commercially available reagent is added to each well of the SBA plate, and the resulting luminescence signal is measured in a microplate reader. The signal obtained is proportional to the ATP present, which is directly proportional to the number of viable bacteria. Bactericidal activity is subsequently calculated. We demonstrated the applicability of L-SBA with multiple bacterial serovars, from 5 species: Citrobacter freundii, Salmonella enterica serovars Typhimurium and Enteritidis, Shigella flexneri serovars 2a and 3a, Shigella sonnei and Neisseria meningitidis. Serum bactericidal titers obtained by the luminescence readout method strongly correlate with the data obtained by the conventional agar plate-based assay, and the new assay is highly reproducible. L-SBA considerably shortens assay time, facilitates data acquisition and analysis and reduces the operator dependency, avoiding the plating and counting of CFUs. Our results demonstrate that L-SBA is a useful high-throughput bactericidal assay.
url http://europepmc.org/articles/PMC5305226?pdf=render
work_keys_str_mv AT francescanecchi developmentofahighthroughputmethodtoevaluateserumbactericidalactivityusingbacterialatpmeasurementassurvivalreadout
AT allansaul developmentofahighthroughputmethodtoevaluateserumbactericidalactivityusingbacterialatpmeasurementassurvivalreadout
AT simonarondini developmentofahighthroughputmethodtoevaluateserumbactericidalactivityusingbacterialatpmeasurementassurvivalreadout
_version_ 1725944788504543232